Billiontoone Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Billiontoone Inc 's ROA in the second quarter of 2026?
Billiontoone Inc achieved a return on average assets (ROA) of 5.61 % in its second quarter of 2026, this is above BLLN's average return on assets of 0%.
Billiontoone Inc assets over the 12 months ending in its second quarter of 2026 are valued at $598 million

Despite the company's net income deteriorating, Billiontoone Inc was able to improve its ROA compared to the first quarter of 2026.

However, within the Healthcare sector Billiontoone Inc achieved the highest return on assets. While the total ranking for ROA unchanged, relative to the first quarter of 2026 at no. .

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	89.02 %	-	-	-	-
Y / Y Net Income Change	-	-95.67 %	-98.52 %	-	-
Net Income (TTM) in million	34	25	423	821	820
Return On Assets (TTM)	5.61 %	4.93 %	125.58 %	460.33 %	849.3 %
BLLN's Total Ranking	#	#	#	#	#
Total Assets (TTM) in million	730	701	633	328	386
Seq. Total Assets Change	4.13 %	10.76 %	93.16 %	-15.16 %	-
Seq. Net Income Change	-55.18 %	200.65 %	296.62 %	-	-

BLLN's 5 Years Annual ROA >> Back to BLLN Management Effectiveness >> Compare BLLN ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Assets Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Billiontoone Inc 's Assets	$ 730 million	BLLN's Balance sheet
Billiontoone Inc 's Income	$ 8 million	Quarterly BLLN's Income Statement
BLLN's Income by Division		See BLLN's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	FY	FY	FY	FY
Y / Y Total Assets Change	-	-	-	-	-
Total Assets in million	633	0	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	3	0	0	0	0
Annual Return On Assets	0.46 %	-	-	-	-

BLLN's 5 Years Annual ROA >> Back to BLLN Management Effectiveness >> Compare BLLN ROA to its Competitors

Comment on BLLN's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA deteriorated to 0.46 %, despite annual net income growth of % to $2.92 million, from $0.00 million a year ago, as BLLN's assets increase to $632.65 million, by %.

More Return On Assets Ratios
BLLN's' Return on Assets at Yahoo Finance
Medical Laboratories Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
BLLN's Roa Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for BLLN's Competitors
Subscribers only: Roa for Billiontoone Inc 's Suppliers
Subscribers only: Return On Assets for BLLN's Customers

You may also want to know
BLLN's Roi	BLLN's Inventory Turnover Ratio	BLLN's Growth Rates	BLLN's Dividend Comparisons
	BLLN's Profitability Ratios	BLLN's Asset Turnover Ratio	BLLN's Dividend Growth
BLLN's Roe	BLLN's Valuation Ratios	BLLN's Financial Strength Ratios	BLLN's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector	ROA
Healthcare Services Group Inc	15.21 %
Inspire Medical Systems inc	15.21 %
Dexcom Inc	14.87 %
Neurocrine Biosciences Inc	14.73 %
Entera Bio Ltd	14.60 %
Standard Biotools Inc	14.31 %
Arcutis Biotherapeutics Inc	14.23 %
Harmony Biosciences Holdings inc	14.15 %
Biolife Solutions Inc	14.09 %
Aveanna Healthcare Holdings Inc	13.82 %
West Pharmaceutical Services Inc	13.64 %
Medinotec Inc	13.38 %
Puma Biotechnology Inc	13.28 %
Sbc Medical Group Holdings Incorporated	13.26 %
Alpha Pro Tech Ltd	13.17 %
Illumina Inc	12.68 %
Spero Therapeutics Inc	12.57 %
Transmedics Group Inc	12.50 %
Eton Pharmaceuticals Inc	12.37 %
Nephros Inc	12.30 %
Msa Safety Inc	12.23 %
Strata Critical Medical Inc	12.18 %
Insulet Corporation	12.13 %
Lantheus Holdings Inc	11.89 %
Ligand Pharmaceuticals Incorporated	11.68 %
Theravance Biopharma inc	11.68 %
Carlisle Companies Incorporated	11.62 %
Encompass Health Corporation	11.60 %
Protagonist Therapeutics inc	11.02 %
Agilent Technologies inc	10.97 %

Date modified: 2026-09-08T15:11:45+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.